Literature DB >> 1659990

Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5.

W Q Jiang1, L Szekely, V Wendel-Hansen, N Ringertz, G Klein, A Rosén.   

Abstract

A monoclonal antibody (aRB1C1) raised against an Rb fusion protein detects a limited number (4-10) of relatively large intranuclear foci in an EBV-immortalized cord blood cell line (IB4). These domains also bind an anti-EBNA-5 monoclonal antibody. The Rb antibody reactive sites also co-localize with the SV40 T antigen in transformed monkey cells (COS). The nuclear structures stained by aRB1C1 and EBNA-5 antibodies are distinct from the structures detected with antibodies against centromeric proteins and certain snRNP epitopes. EBNA-5/Rb-positive domains do not selectively react with antibodies against the La antigen known to associate with the small EBV-encoded nuclear RNA species designated as the EBERs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659990     DOI: 10.1016/0014-4827(91)90438-z

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  16 in total

1.  Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.

Authors:  R Peng; J Tan; P D Ling
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 2.  The expression and function of Epstein-Barr virus encoded latent genes.

Authors:  L S Young; C W Dawson; A G Eliopoulos
Journal:  Mol Pathol       Date:  2000-10

3.  Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.

Authors:  R Peng; A V Gordadze; E M Fuentes Pananá; F Wang; J Zong; G S Hayward; J Tan; P D Ling
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.

Authors:  Rongsheng Peng; Stephanie C Moses; Jie Tan; Elisabeth Kremmer; Paul D Ling
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Multiple functions within the Epstein-Barr virus EBNA-3A protein.

Authors:  I Cludts; P J Farrell
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein.

Authors:  M Alcalay; L Tomassoni; E Colombo; S Stoldt; F Grignani; M Fagioli; L Szekely; K Helin; P G Pelicci
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

7.  Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100.

Authors:  Paul D Ling; Rong Sheng Peng; Ayako Nakajima; Jiang H Yu; Jie Tan; Stephanie M Moses; Wei-Hong Yang; Bo Zhao; Elliott Kieff; Kenneth D Bloch; Donald B Bloch
Journal:  EMBO J       Date:  2005-09-22       Impact factor: 11.598

8.  Cell cycle stage-specific phosphorylation of the Epstein-Barr virus immortalization protein EBNA-LP.

Authors:  M K Kitay; D T Rowe
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies.

Authors:  L Szekely; K Pokrovskaja; W Q Jiang; H de The; N Ringertz; G Klein
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

Authors:  L Szekely; G Selivanova; K P Magnusson; G Klein; K G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.